author-photo

Ellen Napier

University of Pennsylvania

11

Papers

57

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Tisagenlecleucel Therapy: Nursing Considerations for the Outpatient Setting.

2021 Seminars in Oncology Nursing
Show All
- Source
- Cite
- Save
Citations (0)
Ibrutinib before Apheresis May Improve Tisagenlecleucel Manufacturing in Relapsed/Refractory Adult Diffuse Large B-Cell Lymphoma: Initial Results from a Phase 1b Study

2020 Blood
Show All
- Source
- Cite
- Save
Citations (3)
A phase Ia/Ib study of a novel BTK inhibitor, DTRMWXHS-12 (DTRM-12), and combination products, with everolimus and pomalidomide, in pts with CLL or other B-cell lymphomas.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Simultaneous Global Phase I Studies of a Differentiated BTK Inhibitor, Dtrmwxhs-12, in Relapsed/Refractory Patients with Chronic Lymphocytic Leukemia and B-Cell Lymphomas

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Lenalidomide Maintenance after Autologous Stem Cell Transplant in Patients with High-Risk Relapsed/Refractory Lymphomas Is Feasible and Compares Favorably to Historical Controls: Results of a Phase I/II Trial

2016 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Brentuximab Vedotin in Combination with Multi-Agent Chemotherapy Is Well Tolerated and Shows Promising Activity As Frontline Treatment for Primary Mediastinal B-Cell Lymphoma

2015 Blood
Show All
- Source
- Cite
- Save
Citations (3)